CNCAV: 3,002 persons take their first COVID 19 vaccine dose in past 24hrs
Publicat:A total of 17,316 doses of Pfizer, Moderna and Johnson&Johnson vaccines have been administered in the past 24 hours, of which 3,002 represent the first dose, 3,261 - the second dose and 11,053 - the third dose, the National Coordinating Committee for Vaccination Activities against COVID-19 informed on Tuesday.
According to the CNCAV, since the beginning of the vaccination campaign, on December 27, 2020, 16,341,192 doses of vaccine have been administered to 8,052,965 people, 7,953,727 having been fully vaccinated and 2,318,752 also having taken the third dose, Agerpres.ro informs.
Six…
Citeste articolul mai departe pe stiripesurse.ro…
Sursa articol: stiripesurse.ro
Stiri pe aceeasi tema
Batalia dintre Pfizer și Moderna privind vaccinurile anti-Covid incepe la Londra
15:01, 23.04.2024 - Pfizer și partenerul sau german BioNTech au cerut unei instanțe de la Londra sa revoce brevetele pe care rivalii de la Moderna l-au obținut pentru tehnologia cheie in dezvoltarea vaccinurilor anti-Covid, batalia juridica incepand marți in capitala britanica, relateaza Reuters.
Ministrul Sanatații a facut anunțul. Cate doze de vaccin anti-Covid au fost distruse pana acum
18:30, 02.04.2024 - Alexandru Rafila a fost intrebat, luni seara, la un post TV, despre vaccinurile anti-COVID-19 pe care le-a cumparat Romania in pandemie.Ministrul Sanatatii a explicat ca s-au contractat initial 94 de milioane de doze, fiind redusa cantitatea la 80 de milioane.”S-au achizitionat efectiv 36 - 37 milioane…
Actualitate medicala/ BioNTech spera sa lanseze un prim medicament anticancer in 2026
00:20, 25.03.2024 - Laboratorul german BioNTech, care a dezvoltat unul dintre vaccinurile inovatoare impotriva COVID-19, a precizat recent ca isi propune comercializarea unui prim medicament impotriva cancerului in 2026, in principal gratie tehnologiei ARN mesager (ARNm), informeaza AFP, preluata de Agerpres. „Compania…
BioNTech spera sa lanseze un prim medicament anticancer in 2026
08:00, 24.03.2024 - BioNTech, Laboratorul care a Dezvoltat un Vaccin impotriva COVID-19, Vizeaza un Medicament Anticancer Revoluționar Laboratorul german BioNTech, cunoscut pentru dezvoltarea unuia dintre cele mai inovatoare vaccinuri impotriva COVID-19, și-a anunțat intenția de a lansa primul sau medicament impotriva…
Tratament contra cancerului, adaptat fiecarui pacient, de la BioNTech
06:25, 22.03.2024 - Compania BioNTech a anunțat ca vizeaza comercializarea in 2026 a unui prim tratament oncologic bazat pe tehnologia ARN mesager, adaptat fiecarui pacient. Tratamentele viitorului contra cancerului nu mai vizeaza combaterea bolii, ci pregatirea sistemului imunitar al pacientului de a face fața acesteia.…
Over 441,400 tonnes of wheat and 301,000 tonnes of corn from Ukraine, in transit through Romania
19:00, 20.02.2024 - Quantities of 988,152 tonnes of wheat and 18,286 tonnes of corn were placed, between May 2 and December 31, 2023, in transit on the territory of Romania, with Ukraine as the country of dispatch, through 14,584 operations, according to the data published on Tuesday by the Romanian Customs Authority (AVR).…
40 COVID-19 Omicron cases reported in Romania, Jan 24-Feb 4
12:20, 06.02.2024 - As many as 40 cases of SARS-CoV-2 Omicron were confirmed in Romania in the week of January 24 - February 4, of which 8 deemed variants of interest (VOIs), the National Public Health Institute (INSP) informed on Tuesday.According to the cited source, 207 infections with the BA.2.75 COVID-19 sub-variant…
Retail media market in Romania to exceed 10 million euros in 2024 (estimates)
12:05, 30.01.2024 - The retail media market in Romania will exceed 10 million euros in 2024, after 7.5 million euros last year, according to a specialist analysis published on Tuesday.The growth of this market by more than 30%, year-on-year, is reflected in the growing number of retailers developing and consolidating…
se inchide automat in 30 secunde
